» Articles » PMID: 36171050

Early Experiences of the Your COVID Recovery Digital Programme for Individuals with Long COVID

Overview
Date 2022 Sep 28
PMID 36171050
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe the early data from the Your COVID Recovery digital programme and to explore the data collected from two embedded outcome measures.

Design: Observational.

Setting: Primary and secondary care (England-Online).

Participants: 110 individuals completed the programme (68.1% female, 88.1% White British, age: 46.3 (10.8) years, weight: 86.5 (21.1) kg, height: 169.3 (10.0) cm). 47.2% of patients reported comorbidities.

Intervention: Following an assessment by a healthcare professional, individuals with long COVID were offered access to the Your COVID Recovery digital programme. The programme comprises of four stages for the participants to progress through. Participants are encouraged to record severity of their symptoms and amount of activity they are doing on a symptom and an activity tracker. Resources and interactive material on managing symptoms of long COVID are available throughout each stage.

Primary Outcome Measures: Questionnaire (EuroQ0l 5-Dimension 5-Level (EQ-5D-5L) and the chronic obstructive pulmonary disease assessment test (CAT)) data were extracted from the site from 11 March 2021 until 9 November 2021.

Results: Participants were on the programme for 8.6 (4.3) weeks. There was a statistically significant increase in EQ-5D-5L visual analogue scale (VAS) score (pre=48.8 (19.5); post=59.9 (22.1); p<0.01). The EQ-5D-5L Index Value preintervention to postintervention did improve but not significantly (pre=0.5 (0.3); post=0.6 (0.3); p=0.09). CAT total score improved significantly preintervention to postintervention (pre=19.8 (7.2); post=15.6 (7.6); p<0.01). All CAT item scores significantly improved preintervention to postintervention (p<0.005), except the phlegm item score (p=0.168).

Discussion: This early data describes the impact of the Your COVID Recovery digital programme on the first cohort of patients to complete the digital recovery programme. The outcome data are promising and should encourage uptake.

Citing Articles

Rehabilitation interventions and outcomes for post-COVID condition: a scoping review.

Saunders E, Pouliopoulou D, Miller E, Billias N, MacDermid J, Brunton L BMJ Public Health. 2025; 3(1):e001827.

PMID: 40017924 PMC: 11865788. DOI: 10.1136/bmjph-2024-001827.


Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.

Henderson A, Butler-Cole B, Tazare J, Tomlinson L, Marks M, Jit M EClinicalMedicine. 2024; 72:102638.

PMID: 38800803 PMC: 11127160. DOI: 10.1016/j.eclinm.2024.102638.


Investigating Scottish Long COVID community rehabilitation service models from the perspectives of people living with Long COVID and healthcare professionals: a qualitative descriptive study.

Duncan E, Alexander L, Cowie J, Love A, Morris J, Moss R BMJ Open. 2023; 13(12):e078740.

PMID: 38101833 PMC: 10729197. DOI: 10.1136/bmjopen-2023-078740.


Efficacy of Pulmonary Rehabilitation in Post-COVID-19: A Systematic Review and Meta-Analysis.

Melendez-Oliva E, Martinez-Pozas O, Cuenca-Zaldivar J, Villafane J, Jimenez-Ortega L, Sanchez-Romero E Biomedicines. 2023; 11(8).

PMID: 37626710 PMC: 10452542. DOI: 10.3390/biomedicines11082213.


Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management.

Yan M, Yang M, Lai C Viruses. 2023; 15(2).

PMID: 36851746 PMC: 9964207. DOI: 10.3390/v15020533.

References
1.
Daynes E, Gerlis C, Briggs-Price S, Jones P, Singh S . COPD assessment test for the evaluation of COVID-19 symptoms. Thorax. 2020; 76(2):185-187. DOI: 10.1136/thoraxjnl-2020-215916. View

2.
Daynes E, Gerlis C, Chaplin E, Gardiner N, Singh S . Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study. Chron Respir Dis. 2021; 18:14799731211015691. PMC: 8114752. DOI: 10.1177/14799731211015691. View

3.
Kon S, Canavan J, Jones S, M Nolan C, Clark A, Dickson M . Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014; 2(3):195-203. DOI: 10.1016/S2213-2600(14)70001-3. View

4.
Jones P, Harding G, Wiklund I, Berry P, Leidy N . Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009; 18(3):208-15. PMC: 6619275. DOI: 10.4104/pcrj.2009.00053. View

5.
Stavem K, Ghanima W, Olsen M, Gilboe H, Einvik G . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020; 76(4):405-407. PMC: 7716295. DOI: 10.1136/thoraxjnl-2020-216377. View